COMMUNIQUÉS West-GlobeNewswire

BioSyent Releases Results for Fourth Quarter and Full Year 2017
21/03/2018
TORONTO, March 21, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) released today a summary of its financial results for the three and twelve months ended December 31, 2017. Key highlights include: [...]
Albireo to Present at 17th Annual Needham & Company Healthcare Conference
21/03/2018
BOSTON, March 21, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]
BioSig Technologies Announces Participation in Bates College’s Purposeful Work Initiative
21/03/2018
Santa Monica, CA, March 21, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Incysus to Present at BioCentury Future Leaders Conference
21/03/2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, announced today that [...]
Clearside Biomedical to Present at the 17th Annual Needham Healthcare Conference
21/03/2018
ALPHARETTA, Ga., March 21, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]
Caelum Biosciences Announces Clinical Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentation at 16th International Symposium on Amyloidosis
21/03/2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ: FBIO ) Company developing treatments for rare and life-threatening diseases, today announced that the [...]
Arch Biopartners Granted Pre-Ind Meeting With FDA for Candidate Drug to Prevent Acute Kidney Injury
21/03/2018
TORONTO, March 21, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB: ACHFF ), announced today that a Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and [...]
Easton Pharmaceuticals Announces Development of a Blockchain and Cryptocurrency Initiative
21/03/2018
TORONTO, ON, March 21, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals, Inc. (OTC: EAPH), announces it has initiated discussions for the development of a blockchain platform and cryptocurrency that will streamline the [...]
Chiesi to Become Presenting Sponsor of North Carolina Football Club’s Spread Your Wings Foundation
21/03/2018
CARY, N.C., March 21, 2018 (GLOBE NEWSWIRE) -- The North Carolina Football Club announced today that Chiesi (key-A-zee), a Cary-based specialty pharmaceutical company, will become the presenting sponsor of the club’s [...]
Checkpoint Therapeutics Initiates Dose Expansion Portion of Phase 1 Trial of Anti-PD-L1 Antibody CK-301
21/03/2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Cidara Therapeutics Provides Clinical Data Updates for its Lead Antifungal Rezafungin
21/03/2018
Additional data and analyses from STRIVE Phase 2 clinical trial confirm positive efficacy results in both rezafungin arms Definitive Phase 1 QT clinical trial showed no cardiac abnormalities SAN DIEGO, March 21, 2018 ( [...]
Meridian Bioscience Realigns Organizational Structure
21/03/2018
New Structure Consists of two Business Units, Diagnostics and Life Science, Supported by a Global Corporate Team Realignment Aimed at Building a Stronger, More Sustainable Organization; Paving the Way for Future Growth [...]
Helix BioPharma Corp. Signs Collaboration Agreement With ProMab Biotechnologies to Co-Develop CAR-T for Hematological Malignancies
21/03/2018
RICHMOND HILL, Ontario, March 21, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ), (FSE:HBP) (“Helix” or the “Company”), a immuno-oncology company developing innovative drug candidates for the prevention and [...]
Geron to Present at the Needham Healthcare Conference
21/03/2018
MENLO PARK, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the 17th Annual [...]
KemPharm, Inc. to Report Fourth Quarter and Year End 2017 Results
21/03/2018
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for March 29th, 2018, 4:30 p.m. ET CORALVILLE, Iowa, March 21, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH ), a specialty pharmaceutical [...]
SuperSonic Imagine’s Aixplorer® Ultimate Highlighted at American Institute of Ultrasound in Medicine Meeting in New York
21/03/2018
Aix-en-Provence, France, March 21, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will highlight its premium [...]
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2017 Financial Results
21/03/2018
BERKELEY HEIGHTS, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target [...]
Leap Therapeutics to Present at the 2018 Needham & Company 17th Annual Healthcare Conference
21/03/2018
CAMBRIDGE, Mass., March 21, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, [...]
Bringing Generations Together Through Music
21/03/2018
DALLAS, March 21, 2018 (GLOBE NEWSWIRE) -- According to research, music and intergenerational interaction 1 can enhance cognitive abilities and quality of life in children 2 , parents, and seniors 3 . As part of its [...]

Pages